Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.00    0.00 (0.00%)
Bid:
115.00
Ask:
116.00
Spread: 1.00 (0.87%)
Market Cap: £254.20m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Company Update Presentation

27 Apr 2021 07:00

RNS Number : 6427W
Real Estate Credit Investments Ltd
27 April 2021
 

27 April 2021

 

Real Estate Credit Investments Limited

 

Company Update Presentation

 

Real Estate Credit Investments Limited ("RECI" or "the Company") is pleased to advise investors of the release of its latest Company Update Presentation.

 

Given the ongoing uncertainty evolving from the COVID-19 pandemic, RECI's Investment Manager has prepared the Company Update Presentation to provide investors with:

 

 

an update of the position of the Company as at 31 March 2021;

a detailed review of the portfolio investments held by the Company; and

detail of the Company's strategy with regards to dividends, leverage, liquidity and opportunities in the UK and European real estate credit markets.

 

The Company is pleased to announce that the Company Update Presentation is now available on the Company's website at:

 

https://www.recreditinvest.com/investors/results-reports-and-presentations/#currentPage=1

 

An extract from the Summary section of the Company Update Presentation is set out for investors in the Appendix to this announcement.

 

For further information, please contact:

 

Broker: Richard Crawley / Richard Bootle (Liberum Capital) +44 (0)20 3100 2222

Investment Manager: Richard Lang (Cheyne) +44 (0)20 7968 7328

 

 

 

Appendix: Company Update Presentation Extract

 

Summary: The Investment Opportunity

 

· Attractive returns from low LTV credit exposure to UK and European commercial real estate assets

o Weighted Average LTV of 64.9% as at 31 March 2021

o Predominantly large, well capitalised, and experienced institutional borrowers

· Quarterly dividends delivered consistently since October 2013

o The Company has consistently sought to pay a stable quarterly dividend

o This has led to a stable annualised dividend of around 7% of NAV

o Maintaining dividend policy for March 2021 year end as announced in May 2020

· Highly granular book

o 61 positions

o Top position: 14.1% of NAV (by commitment) as at 31 March 2021

· Transparent and conservative leverage

· Access to established real estate investment team at Cheyne, which manages over $4bn AUM

· Access to pipeline of enhanced return investment opportunities identified by Cheyne

· Robust mitigation against a rising rates environment

o A high yielding portfolio, combined with a short weighted average life of 1.9 years, ensures minimal exposure to yield widening and the ability to redeploy quickly at higher rates

 

Summary: Responding to COVID

 

· Market

o Due to banks still not lending, Cheyne has become a "go to" lender

· Portfolio

o No defaults due to robust positions. Move to more senior positions

o Mark to Market recovery of 4.1p to NAV since initial COVID-19 impact in March 2020

· Cash

o Cash reserves maintained at between 5% to 10% of NAV

· Dividend

o Dividends maintained at 3.0p per quarter, 8.8% yield, based on share price, as at 31 March 2021

· Discount

o Average discount during 2021 calendar year to date of 6.4%, from >40% at peak

· Opportunities

o Increased returns at more defensive LTVs

 

Summary: Structural Strength - Positioned to Capitalise on Opportunities

 

· Having successfully navigated through the challenges posed by the COVID-19 pandemic, RECI is well positioned to address future market uncertainty, with a strong portfolio profile and modest leverage comprising:

o Senior loans and bonds equal to 82% of NAV

o Weighted average LTV of 64.9%

o The portfolio is concentrated on credits to large, well capitalised and experienced institutional borrowers

o Leverage of 1.23x gross (1.16x net of cash held) as at 31 March 2021

o Cash on balance sheet of £22.8m

· The Company has good visibility on its liquidity and income profile for the next financial year ending March 2022, and beyond

· The Company is positioned to take advantage of a new pipeline of opportunities from a position of strength

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZGZDNVRGMZM
Date   Source Headline
20th Dec 20242:06 pmRNSDirector/PDMR Shareholding
17th Dec 20243:13 pmRNSFact Sheet Announcement
28th Nov 20243:04 pmRNSDirector/PDMR Shareholding
28th Nov 20247:00 amRNSDividend Declaration
28th Nov 20247:00 amRNSHalf-year Report
12th Nov 20247:00 amRNSFact Sheet Announcement
5th Nov 20247:00 amRNSDirector Appointment
28th Oct 20247:00 amRNSShare Buyback Programme in a Closed Period
15th Oct 20247:00 amRNSFact Sheet Announcement
10th Oct 20242:25 pmRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSFact Sheet Announcement
30th Sep 20243:30 pmRNSBoard Succession Update
27th Sep 20247:00 amRNSFurther Buyback Programme
25th Sep 20244:43 pmRNSHolding(s) in Company
18th Sep 20244:30 pmRNSDividend Declaration
18th Sep 20243:59 pmRNSResult of AGM and Directorate Change
10th Sep 20247:01 amRNSFact Sheet Announcement
10th Sep 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20244:56 pmRNSHolding(s) in Company
16th Aug 20245:10 pmRNSHolding(s) in Company
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20249:11 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSFact Sheet Announcement
12th Aug 20247:00 amRNSNotice of AGM
9th Aug 20243:00 pmRNSHolding(s) in Company
5th Aug 20245:00 pmRNSHolding(s) in Company
16th Jul 20242:11 pmRNSNew Transaction
9th Jul 20247:00 amRNSFact Sheet Announcement
20th Jun 20247:00 amRNSDividend Declaration
20th Jun 20247:00 amRNSAnnual Financial Report
18th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 202412:30 pmRNSBoard Changes
11th Jun 20245:08 pmRNSHolding(s) in Company
10th Jun 20247:00 amRNSFact Sheet Announcement
28th May 20249:19 amRNSDirector Declaration
21st May 20244:00 pmRNSShare Buyback Programme in a Closed Period
15th May 20244:06 pmRNSHolding(s) in Company
13th May 20247:00 amRNSFact Sheet Announcement
8th May 20247:00 amRNSDirector Appointment
2nd May 20247:00 amRNSNotice of RECI Investor Day
25th Apr 20242:30 pmRNSHolding(s) in Company
16th Apr 202411:56 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSFact Sheet Announcement
4th Apr 20244:50 pmRNSDirector/PDMR Shareholding
3rd Apr 20245:31 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSSuccessor Buyback Programme
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20243:11 pmRNSHolding(s) in Company
22nd Mar 20244:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.